Pandemic profiteering: Gilead Sciences cashes in on COVID-19 – World Socialist Web Site

Pharmaceutical giant Gilead Sciences announced Monday that it will charge $3,120 for a five-day course of its coronavirus therapeutic remdesivir for the vast majority of the US population, including those on Medicare and Medicaid. A single vial of remdesivir, containing a tenth of a gram of the drug, will cost $520, a hundred times more expensive than its weight in gold.

This is nothing less than the extortion of the American public amid the COVID-19 pandemic. The price is estimated to be 400 times higher than what the drug needs to be profitable. Gilead is expected to make $1.3 billion from private payers by the end of the year.

Pandemic profiteering: Gilead Sciences cashes in on COVID-19 – World Socialist Web Site